OncoSystem Directory
Explore organizations in the global Oncology ecosystem
724 organization(s) found
South African NCR (National Cancer Registry)
The South African National Cancer Registry (NCR), is a division of National Health Laboratory Services (NHLS). The NCR serves as South Africa’s main source of national cancer incidence data. Since 1986, the NCR has conducted pathology-based cancer surveillance, where data on cancer cases diagnosed by histology, cytology and bone marrow aspirate and trephine are collected, analysed and reported annually.
Johannesburg, South Africa
WebsiteSouth African Oncology Social Workers’ Forum (SAOSWF)
Professional association for social workers specializing in oncology — promoting psychosocial care for cancer patients and families.
Cape Town, South Africa WebsiteSPOM (Sociedad Peruana de Oncología Médica)
In Spanish: "Somos una Organización Científica sin fines de lucro orientada a liderar, en el ámbito nacional los conocimientos relacionados al cáncer, a su investigación y al tratamiento médico. Formamos parte de las Sociedades Médicas del Colegio Médico del Perú, como Sociedad Principal, al cual estamos acreditados legalmente. La Sociedad Peruana de Oncología Médica fue fundada en 1996, por un grupo de oncólogos clínicos que tenían como objetivo común agrupar a todos aquellos especialistas que creyeran en la unificación de criterios y esfuerzos en el manejo del cáncer en el Perú."
N/A, Peru
WebsiteSSC (Senegalese Society of Cancerology)
Professional association for clinicians and researchers focusing on cancer care in Senegal.
Dakar, Senegal WebsiteState Key Laboratory of Oncogenes and Related Genes (Shanghai Cancer Institute)
State-level key laboratory focused on molecular oncology, tumor microenvironment, molecular pathology, gene-therapy research — a pillar of China’s basic cancer-science infrastructure. (shsmu.edu.cn)
Shanghai, China WebsiteStep Pharma
Driving a step change in the treatment of cancer. The world leader in CTPS1 inhibition for the targeted treatment of cancer.
Small-molecule inhibitors of cytidine triphosphate synthase 1 (CTPS1) Saint-Genis-Pouilly, France WebsiteStipple Bio
We are revolutionizing targeted oncology with epitope level precision to develop life changing medicines for people with cancer.
Epitope-focused, modality agnostic Precision Oncology Cambridge, MA, United States WebsiteSTORM Therapeutics
STORM Therapeutics is a clinical-stage biotechnology company pioneering cellular reprogramming through RNA modifications to treat disease. Its world leading understanding of RNA modifying enzymes (RME) has led to the discovery of breakthrough small-molecule drugs that precisely reprogram cells through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases. Fierce Biotech named STORM as one of its 2022 “Fierce 15”.
Drugs that target RNA-modifying enzymes for Oncology Waterbeach, United Kingdom WebsiteStylus Medicine
Our initial focus is to create in vivo CAR-T therapies. Our approach enables precise, durable CAR-T generation inside the body. These CAR-T treatments leverage a cell-targeted lipid nanoparticle (LNP) to deliver therapeutic payloads directly to immune cells in vivo. This approach has the potential to transform patient treatment, improve patient accessibility and redefine what�s possible in medicine.
Oncology, Autoimmune Disorders, Genetic Diseases, Other Cambridge, MA, United States WebsiteSun Yat-sen University Cancer Center (SYSUCC)
Founded 1964, a top integrated cancer centre in southern China, combining medical treatment, research, prevention, and education. Offers surgery, chemotherapy, radiotherapy, immunotherapy, gene therapy, TCM, etc. (Chine Daily Gouvernement)
Guangzhou, China WebsiteSUO (Society of Urologic Oncology)
The Mission of the Society of Urologic Oncology (SUO) is to enable qualified members primarily interested in the care of patients with malignant GU diseases to meet for the purpose of discussion, development and implementation of ideas to improve care. Our Primary Objectives are to: · Stimulate research and teaching in urologic oncology · Disseminate the principles of urologic oncology to medical profession at large · Bring urologists into a Society whose work is entirely/principally in malignant disease · Being the most qualified organization on matters of urologic oncology · Standardize fellowship training in urologic oncology
WebsiteSutro Biopharma
Sutro is advancing a next-generation antibody-drug conjugate platform designed to deliver single- and dual-payload ADCs that enable meaningful breakthroughs for patients with cancer.
ADCs (including dual-payload ADCs) and other therapies for Oncology and Infectious Diseases South San Francisco, CA, United States WebsiteSyndax
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We believe that it takes a community to build a great medicine, and that is why we are working to set the new standard for developing medicines in the field of oncology - one that revolves around collaboration, shared learning, and excellence. Syndax's mission is to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.
Small molecule inhibitors of Menin and of HDAC1 in solid tumors (and a mAb for GVHD) New York, NY, United States WebsiteTakeda Oncology
Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company. Our nearly three decades of leadership in oncology reflect a commitment to advancing treatment options that enhance and extend the lives of people living with a range of cancers. We're working to ensure that patients everywhere can access and benefit from our portfolio of approved medicines and developing new treatment options for patients with unmet needs. Our pipeline focuses on thoracic, gastrointestinal and hematologic cancers and our core modalities include antibody-drug conjugates (ADCs), complex biologics and small molecules. We see great value in advancing innovation through collaboration with partners who share our aspiration to cure cancer. Together, we strive to bring life-changing medicines to more patients worldwide.
Oncology, Hemato-Oncology, Hematology Cambridge, MA, United States Website